Why patients with multiple sclerosis perceive improvement of gait during treatment with natalizumab?
Language English Country Austria Media print-electronic
Document type Journal Article, Observational Study, Research Support, Non-U.S. Gov't
PubMed
31098724
DOI
10.1007/s00702-019-02013-z
PII: 10.1007/s00702-019-02013-z
Knihovny.cz E-resources
- Keywords
- Gait, Multiple sclerosis, Natalizumab,
- MeSH
- Adult MeSH
- Outcome Assessment, Health Care * MeSH
- Immunologic Factors pharmacology MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Natalizumab pharmacology MeSH
- Gait Disorders, Neurologic drug therapy etiology physiopathology MeSH
- Prospective Studies MeSH
- Multiple Sclerosis, Relapsing-Remitting complications drug therapy physiopathology MeSH
- Severity of Illness Index MeSH
- Exercise Test MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Observational Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Immunologic Factors MeSH
- Natalizumab MeSH
Gait impairment is one of the common manifestations of multiple sclerosis (MS) and contributes to a loss of quality of life. Natalizumab, an anti-α4 integrin monoclonal antibody, has been shown to have an effect in treatment of MS, reducing relapses and inflammatory lesions. Aim of our study was to assess how patients perceive gait impairment over the first year of treatment with natalizumab and what is the objective correlate of this change. This is an open-label prospective observational study. Subjective gait evaluation was measured by Multiple Sclerosis Walking Scale-12 (MSWS-12). Objective gait assessment included Timed 25-Foot Walk Test (T25FW) and spatiotemporal parameters of gait measured by a GAITRite instrument during a self-selected speed of walking (normal walk) and a fast speed of walking (fast walk). We analysed data of 50 patients with a relapsing-remitting form of MS, median EDSS 3.5 (range 1.5-5). MSWS-12 score significantly decreased between the baseline and month 12 of treatment (p < 0.001). Walking velocity and step length were significantly improved in Normal walk tests (p < 0.001). During the Fast walk tests, a step length and a double support time of the gait cycle were significantly improved (p = 0.001). Change in MSWS-12 score confirmed the clinically significant improvement of gait in patients with MS treated with natalizumab for 1 year. The analysis of spatiotemporal gait parameters has shown a significant improvement in self-selected gait velocity and step length.
See more in PubMed
Mult Scler. 1999 Oct;5(5):363-8 PubMed
Mult Scler. 2000 Aug;6(4):286-90 PubMed
Neurology. 2003 Jan 14;60(1):31-6 PubMed
Gait Posture. 2003 Feb;17(1):68-74 PubMed
Neurology. 2004 Jun 8;62(11):2103-5 PubMed
Nature. 1992 Mar 5;356(6364):63-6 PubMed
N Engl J Med. 2006 Mar 2;354(9):899-910 PubMed
Mult Scler. 2006 Oct;12(5):620-8 PubMed
Mult Scler. 2007 Nov;13(9):1168-75 PubMed
J Neurol Sci. 2008 May 15;268(1-2):69-73 PubMed
Mult Scler. 2008 Aug;14(7):988-91 PubMed
Gait Posture. 2009 Jan;29(1):138-42 PubMed
Adv Ther. 2009 Dec;26(12):1043-57 PubMed
Disabil Rehabil. 2010;32(15):1242-50 PubMed
Gait Posture. 2010 Apr;31(4):506-10 PubMed
Eur J Neurol. 2011 Feb;18(2):240-5 PubMed
Gait Posture. 2011 May;34(1):145-7 PubMed
Patient. 2011;4(3):189-201 PubMed
Lancet Neurol. 2011 Aug;10(8):745-58 PubMed
Gait Posture. 2012 May;36(1):154-6 PubMed
PLoS One. 2012;7(4):e35843 PubMed
Health Qual Life Outcomes. 2012 Dec 27;10:155 PubMed
PLoS One. 2013;8(1):e53297 PubMed
PLoS One. 2013;8(3):e58643 PubMed
Mult Scler. 2014 Jul;20(8):1095-101 PubMed
Am J Phys Med Rehabil. 2014 Jun;93(6):461-9 PubMed
Eur Neurol. 2014;71(5-6):247-51 PubMed
J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1190-7 PubMed
Neurology. 2014 Jul 1;83(1):78-86 PubMed
JAMA Neurol. 2014 Nov;71(11):1386-93 PubMed
Eur J Neurol. 2015 Mar;22(3):570-7 PubMed
J Neuroeng Rehabil. 2015 Feb 10;12:14 PubMed
PLoS One. 2015 May 01;10(5):e0125002 PubMed
J Neurol. 2016 Sep;263(9):1796-801 PubMed
Eur Neurol. 2016;76(3-4):99-104 PubMed
Gait Posture. 2017 Jan;51:25-35 PubMed
Mult Scler J Exp Transl Clin. 2015 Aug 05;1:2055217315596993 PubMed
J Am Geriatr Soc. 1997 Mar;45(3):313-20 PubMed
